The FAST Innovation Seed Grant funds early-stage, high-risk research to advance new therapies, targets, and biomarkers for Angelman syndrome.
The Innovation Seed Grant from FAST funds bold, early-stage research to advance scientific understanding and treatment options for Angelman syndrome.
NSF BIO supports research combining biology and AI/ML to advance biological discovery or develop AI/ML methods inspired by biological systems, encouraging interdisciplinary collaboration.
The FAST IMPACT Award funds major translational research to advance new therapies for Angelman syndrome from pre-clinical studies to IND-enabling stages, supporting innovative scientific approaches.
Graduate Fellowship in Biomedical Research and Data Science supports doctoral researchers in data-driven cancer research to advance discovery, early detection, treatment, and patient benefit.